Israeli Telehealth Firm TytoCare Receives CE Mark, Launches In Europe

Tyto Care, the Netanya-based telehealth firm that allows for medical examinations and services at home, announced it has received the CE Mark approval for its telehealth solution, which will now be available for use by customers and professionals in Europe.

The company said the CE approval means that they would like to immediately roll out the solution in Europe. The solution, which will take place through partnerships with telehealth companies, health systems, and insurance providers, will include an otoscope, stethoscope, digital camera, and the telehealth platform.

“Receiving CE Mark approval is an important milestone for TytoCare, and a major step in our continued strategic expansion into Europe and other new markets,” said Dedi Gilad, CEO, and co-founder of Tyto Care. “European doctors are struggling to keep up with the increasing medical demand of an aging population and the rise of chronic illnesses. Tyto is uniquely positioned to ease this burden by replicating the quality of in-person doctors’ visits without any barriers to access such as transportation and wait time. We look forward to working with European partners to provide this critical missing link and transform the delivery of traditional primary care.”

The milestone follows the company’s clearance with the US Food and Drug Administration (FDA) and product launch in the United States in 2016. It also gained clearance in the Canadian market in August 2018 when the Health Canada, the department of Canada’s government responsible for national public health approved the company’s solution and made it available to Canadian professionals and consumers.

In January 2018, TytoCare raised $25 million in a funding round led by the world’s largest insurer Ping An Global Voyager Fund from China, along with new and existing and investors, to help launch the company into European and Asian markets.

The company will have an exhibit at MEDICA 2018, the leading international trade fair for the medical sector, in Dusseldorf, Germany from November 12 to 15.